Rep. Tom Price is likely to be grilled in a Wednesday confirmation hearing for his nomination to be Department of Health and Human Services secretary about a new report that he invested in a medical device company just before introducing a bill that would have directly helped the company.
Price bought between $1,001 and $15,000 worth of shares in Zimmer Biomet, according to House records that CNN reviewed. Just days later, the Georgia Republican introduced legislation that would have delayed until 2018 a regulation from the Centers for Medicare and Medicaid Services widely believed to be detrimental to the company.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.